| Issue |
Radioprotection
Volume 61, Number 1, Janvier-Mars 2026
|
|
|---|---|---|
| Page(s) | 55 - 61 | |
| DOI | https://doi.org/10.1051/radiopro/2025027 | |
| Published online | 20 March 2026 | |
Article
Diagnostic reference levels for specific clinical indications of computed tomography scans
1
Department of Medical Radiography, Faculty of Basic Clinical Sciences, University of Ilorin, 240213, Ilorin, Nigeria
2
Department of Biomedical Imaging, Advanced Medical and Dental Institute, Universiti Sains Malaysia, 13200, Penang, Malaysia
3
Department of Radiography, Faculty of Allied Health Sciences, College of Health Sciences, Usmanu Danfodiyo University Sokoto, Nigeria
4
Department of Physics, Nasarawa State University, Keffi, Nasarawa State, Nigeria
5
Department of Medical Radiography and Radiological Sciences, Federal University of Lafia, Nigeria
6
Faculty of Medicine and Health Sciences, Department of Radiological Science, Universiti Putra Malaysia, 43400, Selangor, Malaysia
7
Department of Radiography, Faculty of Allied Health, College of Medical Sciences, University of Maiduguri, Maiduguri, Nigeria
* Corresponding author: This email address is being protected from spambots. You need JavaScript enabled to view it.
; This email address is being protected from spambots. You need JavaScript enabled to view it.
Received:
18
December
2024
Accepted:
24
May
2025
Abstract
Diagnostic reference levels (DRLs) are relevant tools for radiation dose optimization. This study performed a regional survey to evaluate dose values based on specific clinical indications (CIs) for adult Computed Tomography (CT) examinations in Northwestern Nigeria. Ten groups of CIs for diagnostic CT in adult patients were considered based on frequency. Data was collected for CT examinations covering the head, chest, and abdomenopelvic regions performed between 2019 and 2020, per center and CIs. Distributions of Volume CT Dose Index (CTDIvol) and examination Dose-Length Product (DLP) were assessed for each CI and gender. 993 single acquisition examinations were analyzed. Median CTDIvol values were closely gabbed in both genders for all examinations whereas median DLP values were higher for male compared to female patients for head and chest examinations, however, higher in female for abdominopelvic examinations. Median DLP difference in head CIs range from 0.7% in head trauma (1277 vs 1267 mG.cm) to 14% in dementia (1188 vs 1022 mG.cm), 17% in lung tumor (352 vs 292 mG.cm) to 20% in chest lesion with CKD (314 vs 251 mG.cm), and 8.4% in kidney stone (424 vs 463 mG.cm) to 18% in urothelial malignancy (423 vs 517 mG.cm) in abdominopelvic examinations. Analysis revealed no significant difference in median dose values among both genders, male and female for all CIs, F(2, 27) = 3.354, p =.997 for CTDIvol and F(2, 27) = 3.354, p =.998 for DLP. This study provides clinical indication-based dose reference values useful for optimizing clinical CT examinations.
Key words: Computed tomography / radiation dose / dosimetry / optimization
© M. K. Abdulkadir et al., Published by EDP Sciences 2026
This is an Open Access article distributed under the terms of the Creative Commons Attribution License (https://creativecommons.org/licenses/by/4.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
1 Introduction
Computed Tomography (CT) technology evolved rapidly in the past few decades, enabling enormous diagnostic imaging possibilities, faster and more accurate diagnosis than conventional plain radiography (Hsieh and Flohr, 2021; Jin et al., 2021). Multi-slice CT revolutionized CT allowing increased scan coverage and ability to perform whole-body scans in milliseconds. Besides, automatic modulation of radiation exposure to compensate for attenuation (AEC), dual-energy capability that allows investigation of materials with different attenuation characteristics at different energies, and improved detector and algorithm technology enhanced CT image quality and expanded its diagnostic potential (Lell and Kachelrieß, 2023).
However, radiation protection experts are concerned about radiation dose (cumulative and collective) and patient safety with its growing usage (Karavas et al., 2022). Radiation-induced cancer is a health risk associated with medical CT exposures (Bernier et al., 2019; Bahadori et al., 2015). Therefore, dose optimization and adequate patient radiation protection measures became even more relevant (Inoue, 2023).
Diagnostic reference levels (DRLs) are essential and reliable tools for radiation dose optimization (Damilakis and Vassileva, 2021). As per the International Commission on Radiological Protection (ICRP) definition and recommendation of DRL, they are defined or applicable for local, regional, national, and international levels of practice (ICRP, 2017). However, lately, the Eurosafe Imaging and ICRP Report 135 recommend and advocate creating DRLs for specific medical imaging procedures, i.e., DRLs defined for a specific clinical indication (CIs) (ICRP, 2017; Damilakis et al., 2023). Previously, a single CT protocol is set for examination of several CIs and clinical conditions affecting the same body region. However, modifications of technique for optimal image acquisition may vary with CIs. For instance, chest COPD, a CI of chest examinations requires lower image quality requirement; lower dose indices due to natural inherent contrast of the lung parenchyma compared to other CIs of the chest requiring higher image quality; higher dose indices. States, regions and local practices are highly encouraged to develop DRLs for radiological practices. In Nigeria, majority of available CT DRLs are based on surveys of local and regional estimates for various anatomical body regions (Abdulkadir et al., 2021).
In line with increasing global trend of CT usage (Power et al., 2016), previous CT practice surveys in Nigeria showed a consistent increase in CT scanners and examinations; the number of CT scanners rose to about 209 in 2022 (Adejoh et al., 2022). Consequently, the average yearly collective dosage from CT is therefore predicted to rise significantly, which highlights the necessity to promote the use of dose optimization concepts in this population through DRLs. Consequently, the primary objective of this study was to survey, evaluate and estimate DRLs on a regional basis for specific CIs of CT examinations.
2 Materials and methods
2.1 Study design and setting
This study involved a multi-center retrospective survey conducted on patients aged ≥ 18 yr who underwent CT examinations in tertiary hospitals and referral healthcare centers housing radiology departments with functional CT scanners located in Northwestern region of Nigeria between 2020 and 2022. The multi-slice CT scanners were installed between 2010 and 2014.
According to previous surveys in decreasing order of frequency, CT scans of the head, abdominopelvic and chest regions were the most frequently performed adult diagnostic CT examinations in Nigeria (Kabeer et al., 2024; Adejoh et al., 2022; Abdulkadir et al., 2021). However, a list of clinical indications for these anatomical regions has not been defined yet. Consequently, examinations of a particular CI of up to or exceeding 20 within the study period were considered while CI of less than 20 examinations were excluded. This is in keeping with the ICRP guideline for setting DRLs. Eventually, ten CIs covering the head, chest, and abdominopelvic regions were considered (Tab. 1).
Data were retrospectively collected manually via the institution’s radiological information systems or their medical records/archives. For each scanner, at least 10 examinations per CIs was targeted for collection. Data were recorded in preformatted Excel sheets. Patients identifying details were anonymized in line with the confidentiality principle. Therefore, informed consent of the patients was not required. Complete examination data was collected from patients’ CT dose reports. Data collected includes patient demographic information; age, gender, clinical indications (CIs), CT scanner characteristics; image reconstruction algorithm type i.e., filtered back projection (FBP) or iterative reconstruction (IR), scan acquisition parameters; (tube voltage (kV), tube current (mAs), scan time, scan length, scan phase, automatic exposure control (AEC) usage, and field of view (FOV), contrast media usage and dose indices data; (volume weighted CT dose index (CTDIvol) in mGy, dose length product (DLP) in mGy.cm
For the CIs of the head scans, the CTDIvol (mGy) and DLP (mGy.cm) values are given for the 16 cm diameter and 32cm diameter reference phantoms for the CIs of the body regions. We assumed that CTDIvol values agreed with the CT quality criteria (within ± 20% deviation) checked annually and after tube replacement. The DRLs study aims to optimize dose by ensuring image quality, therefore, only CT scan examinations accepted and reported by radiologists were included in this study. Single acquisition parameters for CIs were compared in relation to body region.
Description of clinical practice showing CIs, included number of scanners (scanner type and characteristics)/examinations/acquisitions, and contrast media use (for single acquisition).
2.2 Statistical analysis
Data was analyzed using Statistical Package for Social Sciences (SPSS) software version 23 (SPSS Inc., Chicago, IL, USA), with descriptive statistics used to show proportions and spread. Regional DRLs were defined using the ICRP 135 suggestion, with medians estimated for each center and 75th percentiles for every CI (ICRP, 2017). Furthermore, the DRLs values were again estimated based on the distribution of pooled data for all centers. Data of reference dose indices were found to be normally distributed, hence differences between median values were evaluated using a parametric test (One way ANOVA) with the significant level set at 0.05. One way ANOVA was conducted to examine the difference in median dose values among gender (all gender, male, female) and difference in dose values among CIs of same body region.
3 Result
We reviewed 993 single acquisition examinations collected from four centers, one scanner per center. This included 73.4% head, 8.4% chest and 18.2% abdominopelvic CT examinations. The examinations were of adult patients aged between 18 and 98 yr. Table 1 shows the distribution of examinations collected by CT scanners. The CT scanners manufacturers included General Electric Healthcare (2), Philips (1) and Toshiba Medicals (1). The distribution of the 10 CIs, number of scanners per CI is also presented in Table 1. Of the ten CIs reviewed, the highest percentage (34.0%) were head trauma scans, while the lowest (2.2%) were PE scans (Tab. 1). Figure 1 shows the distribution of CTDIvol and DLP for all evaluated CIs.
Acquisition characteristics are quite similar for each of the three body regions examined. Iterative reconstruction (IR) algorithm and automatic exposure control (AEC) were used in all the examinations. For the CIs of the head region, dominant mean kV used ranged from 121-126 kV, 115-120 kV for CIs of the chest and 120-123 kV for abdominopelvic region CIs. The results of the one-way ANOVA revealed no significant difference in dose values (CTDIvol and DLP) among CIs of same body region, F (3, 24) = 3.008, p =.994, n2= 0.0032; CTDIvol and F (3, 24) = 3.008, p =.859, n2 = 0.030; DLP. And therefore, there was no need to perform a post hoc test since the ANOVA was not significant. The difference between dose estimate based on the distribution of median values per center/scanner and the distribution of pooled data for all centers/scanners (Tab. 2) was below 10% and 20% for CTDIvol and DLP respectively.
There was minimal unevenness in the distribution of examination between the genders (56% males and 44% female). The median CTDIvol value between genders were similar across CIs whereas median DLP values were higher in male patients for head and chest CIs, however, higher in women for abdominopelvic CIs. Median DLP difference in head CIs range from 0.7% in head trauma to 14% in dementia, 17% in lung tumor to 20% in chest lesion with CKD, and 8.4% in kidney stone to 18% in urothelial malignancy. Analysis revealed no significant difference in median dose values among both genders, male and female for all CIs, F(2, 27) = 3.354, p =.997 for CTDIvol and F(2, 27) = 3.354, p =.998 for DLP.
![]() |
Fig. 1 Box plot graphs showing the distributions and comparison of dose CTDIvol (a) and DLP (b) according to clinical indication. The median, maximum value, minimum value, and interquartile range are shown. The cross shows the mean value. |
Distribution of reference dose and Acquisition parameters for single acquisitions examinations of all CIs based on the distribution of pooled data for all centers/scanners.
4 Discussion
In this study, CTDIvol and DLP regional distributions were assessed on 10 CIs of head, chest and abdomen in adult patients. Slight variations in dose across centers observed are common findings in DRLs studies usually linked to differences in scanner manufacturer, model, software, tube current modulation (TCM), and scan acquisition characteristics (Paulo et al., 2020; Foley et al., 2012; Smith-Bindman et al., 2019). For all body region, CTDIvol values were generally closely gabbed for both genders across CIs. In examinations of the head, DLP values were higher in men compared to women patients for the same type of CI examination (Tab. 2). This is probably because men’s heads are bigger and denser than women’s, particularly since most of the scans used automatically modulated tube current (AEC). Similarly, for chest CIs, DLP values were higher in men than women except for PE (Tab. 2), this suggests that men have broader chests than women, Previous studies also noted this (Greyes et al., 2019). On the contrary, for the CIs of abdominopelvic, DLP values for women were higher than for men except for the CI abdominopelvic lesions suggestive of larger abdomen size in women. This may also be related to the size of the lesion detected, altering the patient morphology and size of the abdomen. Nevertheless, our findings corroborate the concept that dose estimates are highly dependent on patient morphology.
When comparing different CIs within the same body region, the study found that brain tumor and head trauma examinations had slightly higher dose values, evidenced by higher tube voltage usage due to high image quality (contrast) requirements for this CIs. Other examinations, such as stroke and dementia, had slightly lower dose values but higher tube current (mAs) usage to compensate for the image noise resulting from the usually smaller slice thickness needed to resolve tissues or small vessels in the brain in this type examinations. The CTDIvol indices were similar across head CIs, but a gap was observed for brain tumor scans due to highest mean tube voltage (125 kV) usage. The study showed gabs in DLP values, reflecting the impact of differences in mean scan length values and usage across head CI examinations, but overall, homogeneous practice was observed.
The study found that chest CT examinations have similar dose values across different CI examinations due to similar exposure factors. However, optimal PE scans may be achieved using lower scan protocol values due to lower image quality requirement of this CI compared to high resolution required to detect minute nodules in the lung tumor scans (Geryes et al., 2019). Besides, lower acquisition values (mean: 115 kV, 144 mAs) (Tab. 2) were used for CKD and often without contrast enhancement due to the high natural contrast of the lung tissue and denser metastatic pulmonary calcifications that characterize this type of examination. The abdominopelvic region showed slightly lower dose values for kidney stone CI scans compared to other CIs, possibly due to high natural contrast between kidney stones and tissues, resulting in lower kV scans (mean 120 kV) (Tab. 2).
Comparing CI DRLs can be challenging because of non-uniformity of number of acquisitions reported by studies (Dalah et al., 2022). This study compared 75th percentile single acquisition dose indices for CIs of adult CT with other NDRLS data (Tab. 3). Differences in dose values were observed, with the largest disparity in head examinations being 42% and 56% higher for CTDIvol and DLP compared to lowest NDRL values (Tab. 3). Indicating a need for CT dose/practice optimization, similar to findings in Hakme et al., in their study (Hakme et al., 2023). Higher dose values may be due to differences in practice and technological advancement. This study utilized less advanced CT scanners, primarily 4-32 slice MSCT, compared to modern models with advanced dose reduction options likely used by the NDRLs. Besides, CT Technology has been confirmed to enhance dose reduction in CT practice (Yadav et al., 2021). Another reason may be the lack of professional medical physicist who would provide guidance for optimized scan protocols in several radiological centers due to relatively small work force of this professionals in the study population and country (Bezak et al., 2023; Obed et al., 2016). Moreover, Geryes et al., opined that centers where medical physicist is involved in radiological practices tend to have low dose indices (Geryes et al., 2019). Nigeria has not yet proposed a national framework for DRLs, which would facilitate the comparison and guidance of local and regional practices. Hence, prompting regulatory authorities to expedite the proposal. However, we suggest that a review of equipment settings and examination protocols according to image quality requirement of each CI could optimize current practice considering the observed differences with NDRLs. Dose evaluation and establishment of DRLs for either body region (morphology) or CIs in line with image quality requirements are relevant tools for radiological dose optimization and patient protection. Dose indices provided in this study (Tab. 2) are to encourage practitioners to periodically investigate and optimize their practices in line with the ALARA principle through dose surveys and comparisons using the 25th, 50th and 75th percentiles indices values. Depending on their capability and resources, size-based evaluations are encouraged, if not possible, age based, anatomic region based, body mass index (BMI) based, or clinical indication-based assessments can be performed.
The study’s limitations include uneven distribution and representation of CIs, particularly in chest examinations, and inconsistencies in scanner contribution, particularly in chest and abdomen examinations. There are incidences of incomplete data due to manual data collection and lack of digital collection systems. Image quality was based on standard set by the facilities, and BMI was not estimated due to inadequately documented weight and height data. Although the study only examined data from four CT facilities, these referral centers can offer important insights into CT practice in the area.
Comparison reference dose values with NDRLs.
5 Conclusion
This study performed a regional survey and evaluation of CT doses based on clinical indications. The results offer a tool for optimizing CT dose that is more aligned with clinical practices. Periodic dose monitoring and optimization strategies must be put in place to enhance patient safety while preserving image quality in CT practice. This study could encourage and serve as reference or guidance for CT clinicians on CT dose evaluation before a national reference is achieved.
Acknowledgments
The authors sincerely appreciate the kind support and cooperation of the radiographers, radiologists and staff of the radiological units of all the centers included in the study.
Funding
This research did not receive any specific funding.
Conflicts of interest
The authors declare that they have no conflict of interest
Data availability statement
All relevant data are included in the study.
Author contribution statement
MK. Abdulkadir: Conceptualization, Methodology, Formal analysis, IY. Izge: Writing- Original draft preparation, Formal analysis, U. Ibrahim: Investigation, JD. Zira: Validation, SA. Audu: Investigation, U. Abubakar: Writing − review & Editing, D. Mohammed: Data curation, A. Mohammed: Investigation, Data curation, NM. Gunda: Visualization, Investigation
Ethics approval
The study received institutional ethical approval from the Health Research Ethics Committee of the Usmanu Danfodiyo University Teaching Hospital, Sokoto (UDUTH/HREC/2022/1137/2).
Informed consent
In this study, patients identifying details were anonymized in line with the confidentiality principle and there was no additional impact or risk to the patients involved. Therefore, informed consent of the patients was not required.
References
- Abdulkadir MK, Izge IY, Yunusa GH, Mohammed A, Osman ND. 2021. Evaluation of age-based radiation dose in paediatric patients received from head CT examination at a tertiary hospital, Nigeria. Radiat Phys Chem 182: 109380. [Google Scholar]
- Aberle C, Ryckx N, Treier R, Schindera S. 2020. Update of national diagnostic reference levels for adult CT in Switzerland and assessment of radiation dose reduction since 2010. Eur Radiol 30(3): 1690–700. https://doi.org/10.1007/s00330-019-06485-1. [CrossRef] [PubMed] [Google Scholar]
- Adejoh T, Ezugwu EE, Erondu FO, Okeji MC, Ijever AW. 2022. How well Nigerian radiographers adhere to pediatrics-specific protocols during computed tomography procedures. Rwanda Med J 79(2): 27-36. https://doi.org/10.4314/rmj.v79i2.4. [Google Scholar]
- Bahadori A, Miglioretti D, Kruger R, Flynn M, Weinmann S, Smith-Bindman R, Lee C. 2015. Calculation of organ doses for a large number of patients undergoing CT examinations. Am J Roentgenol 205(4): 827–833. https://doi.org/10.2214/AJR.14.14135. [Google Scholar]
- Bernier MO, Baysson H, Pearce MS, Moissonnier M, Cardis E, Hauptmann M, Struelens L, et al. 2019. Cohort profile: the EPI-CT study: a European pooled epidemiological study to quantify the risk of radiation-induced cancer from paediatric CT. Int J Epidemiol 48 (2): 379–381. https://doi.org/10.1093/ije/dyy231. [Google Scholar]
- Bezak E, Damilakis J, Rehani MM. 2023. Global status of medical physics human resource − the IOMP survey report. Physica Medica 113: 102670. https://doi.org/10.1016/j.ejmp.2023.102670. [Google Scholar]
- Boone JM, Strauss KJ, Cody DD, McNitt-Gray MF, Toth TL. 2011. American Association of Physicist in Medicine AAPM, Report No. 204: Size-Specific Dose Estimates in Pediatric and Adult Body CT Examinations. MD. [Google Scholar]
- Botwe BO, Schandorf C, Inkoom S, Faanu A, Rolstadaas L, Goa PE. 2021. National indication-based diagnostic reference level values in computed tomography: preliminary results from Ghana. Phys Med 84: 274–284. https://doi.org/10.1016/j.ejmp.2021.03.012. [Google Scholar]
- Damilakis J, Vassileva J. 2021. The growing potential of diagnostic reference levels as a dynamic tool for dose optimization. Phys Med 84: 285–287. https://doi.org/10.1016/j.ejmp.2021.03.018. [CrossRef] [PubMed] [Google Scholar]
- Damilakis J, Frija G, Brkljacic B, Vano E, Loose R, Paulo G, Brat H, Tsapaki V. 2023. European Society of Radiology. How to establish and use local diagnostic reference levels: an ESR EuroSafe Imaging expert statement. Insights Imaging 6; 14 (1): 27. https://doi.org/10.1186/s13244-023-01369-x. [Google Scholar]
- Dalah EZ, Alsuwaidi JS, Hamed MS, Gani AHA, Beevi HAA, Panangatil AG, et al. 2022. Challenges experienced in establishing clinical indication based diagnostic reference levels: pilot study. Eur J Radiol 148: 110046. https://doi.org/10.1016/j.ejrad.2021.110046. [Google Scholar]
- European Commission. 2021. Diagnostic reference levels in thirty-six European countries, Radiation Protection N° 180. Available from: Publications Office of the European Union, Luxembourg. https://op.europa.eu/en/publication-detail/-/publication/a78331f7-7199-11eb-9ac9-01aa75ed71a1. [Google Scholar]
- Foley FJ, McEntee MF, Rainford LA. 2012. Establishment of CT diagnostic reference levels in Ireland. Br J Radiol 85(1018): 1390–1397. https://doi.org/10.1259/bjr/15839549. [CrossRef] [PubMed] [Google Scholar]
- Habib Geryes B, Hornbeck A, Jarrige V, Pierrat N, Ducou H, Le P, Dreuil S. 2019. Patient dose evaluation in computed tomography: a French national study based on clinical indications. Phys Med 61: 18–27. https://doi.org/10.1016/j.ejmp.2019.04.004. [CrossRef] [PubMed] [Google Scholar]
- Hakme M, Rizk C, Francis Z, Fares G. 2023. Proposed national diagnostic reference levels for computed tomography examinations based on clinical indication, patient gender and size and the use of contrast in Lebanon. Radioprot 58 (2): 113–121. https://doi.org/10.1051/radiopro/2023013. [Google Scholar]
- Hsieh J, Flohr T. 2021. Computed tomography recent history and future perspectives. J Med Imaging 8(5): 052109. https://doi.org/10.1117/1.JMI.8.5.052109. [Google Scholar]
- Inoue Y. 2023. Radiation dose management in computed tomography: introduction to the practice at a single facility. Tomograph 9(3): 955–966. https://doi.org/10.3390/tomography9030078. [Google Scholar]
- ICRP Publication 135. 2017. Diagnostic reference levels in medical imaging. Ann ICRP 46: 1–144. https://doi.org/10.1177/0146645317717209. [Google Scholar]
- Jin D, Harrison AP, Zhang L, Yan K, Wang Y, Cai Y, Miao S, Lu L. 2021. Artificial intelligence in radiology. Artifi Intell Med 265–89. https://doi.org/10.1016/B978-0-12-821259-2.00014-4. [Google Scholar]
- Kabeer SM, Aliyu SA, Umar FK, Kamal I, Murat H, Muhammad NA, Karim MKA. 2024. Establishment of diagnostic reference level for routine CT scan examination in Sokoto state, Nigeria. Radioprot 59(3): 197–202. https://doi.org/10.1051/radiopro/2024009. [Google Scholar]
- Karavas K, Ece B, Aydın S, Kocak M, Cosgun Z, Bostanci IE, Kantarci M. 2022. Are we aware of radiation: a study about necessity of diagnostic X-ray exposure. World J Methodol 12(4): 264–273. https://doi.org/10.5662/wjm.v12.i4.264. [Google Scholar]
- Lee KL, Beveridge T, Sanagou M, Thomas P. 2020. Updated Australian diagnostic reference levels for adult CT. J Med Radiat Sci 67(1): 5–15. https://doi.org/10.1002/jmrs.372. [CrossRef] [PubMed] [Google Scholar]
- Lell M, Kachelrieß M. 2023. Computed tomography 2.0: new detector technology, AI, and other developments. Invest Radiol 58(8): 587–601. https://doi.org/10.1097/RLI0000000000000995. [Google Scholar]
- Obed RI, Ekpo ME, Omojola AD, Abdulkadir MK. 2016. Medical physics professional development and education in Nigeria. Med Phys Int J 4: 2. http://mpijournal.org/pdf/2016-02/MPI-2016-02.pdf. [Google Scholar]
- Paulo G, Damilakis J, Tsapaki V, Schegerer AA, Repussard J, Jaschke W, Frija G. 2020. Diagnostic reference levels based on clinical indications in computed tomography: a literature review. Insights Imaging 11(1): 1–9. https://doi.org/10.1186/s13244-020-00899-y. [CrossRef] [PubMed] [Google Scholar]
- Power SP, Moloney F, Twomey M, James K, O’Connor OJ, Maher MM. 2016. Computed tomography and patient risk: facts, perceptions and uncertainties. World J Radiol 8 (12): 902–915. https://doi.org/10.4329/wjr.v8.i12.902. [Google Scholar]
- Public Health England. 2022. National Diagnostic Reference Levels (NDRLs). 11. https://www.gov.uk/government/publications/diagnosticradiologynationaldiagnostic-reference-levels-ndrls/national-diagnostic-referencelevelsndrls#fnref:2 [Accessed 13 February 2024]. [Google Scholar]
- Smith-Bindman R, Wang Y, Chu P, Chung R, Einstein AJ, Balcombe J, et al., 2019. International variation in radiation dose for computed tomography examinations: prospective cohort study. BMJ 2(364): k4931. https://doi.org/10.1136/bmj.k4931. [Google Scholar]
- Tan WS, Foley S, Ryan ML. 2023. Investigating CT head diagnostic reference levels based on indication-based protocols − a single site study. Radiography (Lond) 29(4): 786–791. https://doi.org/10.1016/j.radi.2023.05.003. [Google Scholar]
- The Norwegian Radiation Protection Agency (NRPA). 2018. Representative doses in Norway − 2017 Results from reporting and auditing and the establishment of new national reference values. Radiation Protection Report, 3, Østerås. [Google Scholar]
- UK Health Security Agency. 2019. National Diagnostic Reference Levels (NDRLs) from 19 August 2019. Available from: https://www.gov.uk/government/publications/diagnostic-radiology-national-diagnostic-reference-levels-ndrls/ndrl. [Google Scholar]
- Wachabauer D, R̈othlin F, Moshammer HM, Homolka P. 2020. Diagnostic reference levels for computed tomography in Austria: a 2018 nationwide survey on adult patients. Eur J Radiol 125: 108863. https://doi.org/10.1016/j.ejrad.2020.108863. [CrossRef] [PubMed] [Google Scholar]
- Yadav H, Shah D, Sayed S, Horton S, Schroeder LF. 2021. Availability of essential diagnostics in ten low-income and middle-income countries: results from national health facility surveys. Lancet Global Health 9(11): e1553–e1560. https://doi.org/10.1016/S2214-109X(21)00442-3. [Google Scholar]
Cite this article as: Abdulkadir MK, Izge IY, Ibrahim U, Zira JD, Audu SA, Abubakar U, Mohammed D, Mohammed A, Gunda NM. 2026. Diagnostic reference levels for specific clinical indications of computed tomography scans. Radioprotection 61(1): 55–61. https://doi.org/10.1051/radiopro/2025027
All Tables
Description of clinical practice showing CIs, included number of scanners (scanner type and characteristics)/examinations/acquisitions, and contrast media use (for single acquisition).
Distribution of reference dose and Acquisition parameters for single acquisitions examinations of all CIs based on the distribution of pooled data for all centers/scanners.
All Figures
![]() |
Fig. 1 Box plot graphs showing the distributions and comparison of dose CTDIvol (a) and DLP (b) according to clinical indication. The median, maximum value, minimum value, and interquartile range are shown. The cross shows the mean value. |
| In the text | |
Current usage metrics show cumulative count of Article Views (full-text article views including HTML views, PDF and ePub downloads, according to the available data) and Abstracts Views on Vision4Press platform.
Data correspond to usage on the plateform after 2015. The current usage metrics is available 48-96 hours after online publication and is updated daily on week days.
Initial download of the metrics may take a while.

